top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline

Dec 30, 2024
1 min read

Cambridge, MA and Oxford, England, December 17, 2024 (Business Wire) -- Akamis Bio secured $60 million in Series A Prime funding and forged a licensing agreement with Xuanzhu Biopharma to advance its lead oncology candidate, NG-350A. The funding supports a Phase 1b proof-of-concept study evaluating NG-350A in combination with CRT for rectal cancer patients. The strategic partnership positions Akamis to expand globally while continuing to innovate in tumor-specific gene therapy.

Read full article here.

Recent Posts

Incyte Enters Up to $2B Deal with Star Therapeutics Subsidiary to Expand Drug Pipeline

Wilmington, NC, June 8, 2026 (Reuters) -- Incyte has struck a collaboration agreement valued at up to $2 billion with a subsidiary of Star Therapeutics. The deal is structured around upfront funding

GeneDx Appoints Mark Gardner as President to Drive Expansion and Growth Strategy

Gaithersburg, MD, June 16, 2026 (Business Wire) -- GeneDx has named Mark Gardner as its new president. The appointment is intended to support the company’s next phase of scaling its genomics and pre

Novanta to Acquire Riverpoint Medical for $1.2B

Bedford, MA, June 9, 2026 (Novanta) -- Novanta has announced the acquisition of Riverpoint Medical to strengthen its healthcare and surgical solutions portfolio. The transaction expands Novanta’s ca

Comments

Life Science Headlines

Incyte Enters Up to $2B Deal with Star Therapeutics Subsidiary to Expand Drug Pipeline

GeneDx Appoints Mark Gardner as President to Drive Expansion and Growth Strategy

Novanta to Acquire Riverpoint Medical for $1.2B

Thrombolex Appoints Michael Tutera as Chief Executive Officer

GSK to Acquire Nuvalent in $10.6B Deal to Expand Oncology Portfolio

Apogee Secures $1.3B Blackstone Life Sciences Partnership to Advance Late-Stage Immunology Drug Development

NOWDiagnostics Names Lisa Nibauer as CEO to Drive Innovation and Transformation Strategy

NewLimit Raises $435M Financing Round Led by Founders Fund

West Names Michel Lagarde as CEO to Lead Next Phase of Company Growth

Edgewise Sells Sevasemten Program in Up to $2.65B Deal to Refocus on Cardiovascular Pipeline

bottom of page